Pharma Markets

Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape

By Fore Pharma | Published Date: June 7, 2020 | On-Demand Data

The latest research from Fore Pharma, Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape – 2020, provides comprehensive insights into Dry Age-Related Macular Degeneration pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Dry Age-Related Macular Degeneration market size and drug sales. It also provides insights into Dry Age-Related Macular Degeneration epidemiology and late stage pipeline.

This research covers the following – Dry Age-Related Macular Degeneration treatment options, Dry Age-Related Macular Degeneration late stage clinical trials pipeline, Dry Age-Related Macular Degeneration prevalence by countries, Dry Age-Related Macular Degeneration market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:

– Countries: Germany, France, Italy, Spain, UK, Europe
– Dry Age-Related Macular Degeneration pipeline: Find out drugs in clinical trials for Dry Age-Related Macular Degeneration by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Dry Age-Related Macular Degeneration epidemiology: Find out number of patients diagnosed (prevalence) with Dry Age-Related Macular Degeneration by countries
– Dry Age-Related Macular Degeneration drugs: Identify key drugs marketed and prescribed for Dry Age-Related Macular Degeneration by countries, including trade name, molecule name, and company
– Dry Age-Related Macular Degeneration drugs sales: Find out the sales value for Dry Age-Related Macular Degeneration drugs by countries
– Dry Age-Related Macular Degeneration market valuations: Find out the market size for Dry Age-Related Macular Degeneration drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Dry Age-Related Macular Degeneration drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research: The research helps executives to

– Evaluate commercial market opportunities for Dry Age-Related Macular Degeneration drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Dry Age-Related Macular Degeneration market
– Develop in-depth knowledge of competition and markets
– Analyze Dry Age-Related Macular Degeneration drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Dry Age-Related Macular Degeneration market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies

Table of Contents


1. Dry Age-Related Macular Degeneration Treatment Options
2. Dry Age-Related Macular Degeneration Pipeline Insights
2.1. Dry Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Dry Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Dry Age-Related Macular Degeneration Phase 1 Clinical Trials
3. Dry Age-Related Macular Degeneration Epidemiology Analysis by Countries
4. Germany Dry Age-Related Macular Degeneration Market Insights
4.1. Marketed Drugs for Dry Age-Related Macular Degeneration in Germany
4.2. Germany Dry Age-Related Macular Degeneration Market Size & Forecast
4.3. Germany Dry Age-Related Macular Degeneration Drugs Sales Forecast
4.4. Germany Dry Age-Related Macular Degeneration Market Share Analysis
5. France Dry Age-Related Macular Degeneration Market Insights
5.1. Marketed Drugs for Dry Age-Related Macular Degeneration in France
5.2. France Dry Age-Related Macular Degeneration Market Size & Forecast
5.3. France Dry Age-Related Macular Degeneration Product Sales Forecast
5.4. France Dry Age-Related Macular Degeneration Market Share Analysis
6. Italy Dry Age-Related Macular Degeneration Market Insights
6.1. Marketed Drugs for Dry Age-Related Macular Degeneration in Italy
6.2. Italy Dry Age-Related Macular Degeneration Market Size & Forecast
6.3. Italy Dry Age-Related Macular Degeneration Product Sales Forecast
6.4. Italy Dry Age-Related Macular Degeneration Market Share Analysis
7. Spain Dry Age-Related Macular Degeneration Market Insights
7.1. Marketed Drugs for Dry Age-Related Macular Degeneration in Spain
7.2. Spain Dry Age-Related Macular Degeneration Market Size & Forecast
7.3. Spain Dry Age-Related Macular Degeneration Product Sales Forecast
7.4. Spain Dry Age-Related Macular Degeneration Market Share Analysis
8. UK Dry Age-Related Macular Degeneration Market Insights
8.1. Marketed Drugs for Dry Age-Related Macular Degeneration in UK
8.2. UK Dry Age-Related Macular Degeneration Market Size & Forecast
8.3. UK Dry Age-Related Macular Degeneration Product Sales Forecast
8.4. UK Dry Age-Related Macular Degeneration Market Share Analysis
9. Europe Dry Age-Related Macular Degeneration Market Insights
9.1. Europe Dry Age-Related Macular Degeneration Market Size & Forecast
9.2. Europe Dry Age-Related Macular Degeneration Product Sales Forecast
9.3. Europe Dry Age-Related Macular Degeneration Market Share Analysis
10. Research Methodology

List of Tables


1: Dry Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2020
2: Dry Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2020
3: Dry Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2020
4: Dry Age-Related Macular Degeneration Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Dry Age-Related Macular Degeneration in Germany, 2019
6: Germany Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
7: Germany Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
8: Germany Dry Age-Related Macular Degeneration Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Dry Age-Related Macular Degeneration in France, 2019
10: France Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
11: France Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
12: France Dry Age-Related Macular Degeneration Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Dry Age-Related Macular Degeneration in Italy, 2019
14: Italy Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
15: Italy Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
16: Italy Dry Age-Related Macular Degeneration Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Dry Age-Related Macular Degeneration in Spain, 2019
18: Spain Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
19: Spain Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
20: Spain Dry Age-Related Macular Degeneration Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Dry Age-Related Macular Degeneration in UK, 2019
22: UK Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
23: UK Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
24: UK Dry Age-Related Macular Degeneration Market Events and Trends, 2016 – 2025
25: Europe Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
26: Europe Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025

List of Figures


1: Dry Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2020
2: Dry Age-Related Macular Degeneration Prevalence by Countries, 2016 – 2025
3: Germany Dry Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
4: Germany Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
5: Germany Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
6: Germany Dry Age-Related Macular Degeneration Market – Future Market Share (%), 2025
7: France Dry Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
8: France Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
9: France Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
10: France Dry Age-Related Macular Degeneration Market – Future Market Share (%), 2025
11: Italy Dry Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
12: Italy Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
13: Italy Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
14: Italy Dry Age-Related Macular Degeneration Market – Future Market Share (%), 2025
15: Spain Dry Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
16: Spain Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
17: Spain Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
18: Spain Dry Age-Related Macular Degeneration Market – Future Market Share (%), 2025
19: UK Dry Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
20: UK Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
21: UK Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
22: UK Dry Age-Related Macular Degeneration Market – Future Market Share (%), 2025
23: Europe Dry Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
24: Europe Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
25: Europe Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
26: Europe Dry Age-Related Macular Degeneration Market – Future Market Share (%), 2025

Format


Dispatch format is XLSX.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies